Section Arrow
SNWV.NASDAQ
- Sanuwave Health Inc
(Financial Status)
Quotes are at least 15-min delayed:2026/11/20 17:54 EST
After Hours
Last
 1.5
0 (0.00%)
Bid
1.37
Ask
1.9
High 1.5 
Low 1.45 
Volume 79 
Regular Hours (Closed)
Last
 1.5
-0.09 (-5.66%)
Day High 
1.59 
Prev. Close
1.59 
1-M High
6.1899 
Volume 
57.70K 
Bid
1.37
Ask
1.9
Day Low
1.48 
Open
1.59 
1-M Low
1.5501 
Market Cap 
13.68M 
Currency 美元 
P/E 2.22 
%Yield -- 
10-SMA 1.79 
20-SMA 3.44 
50-SMA 4.31 
52-W High 35.29 
52-W Low 1.5501 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.21/1.54
Enterprise Value
30.85M
Balance Sheet
Book Value Per Share
0.33
Cash Flow
Cash Flow Yield
0.24
Income Statement
Total Revenue
32.63M
Operating Revenue Per Share
0.09
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp41.98-1.01-2.35%18.14PE
After Hours 42.3233 +0.3433 +0.82%
PACBPacific Biosciences of California1.63-0.13-7.39%-- 
After Hours 1.65 +0.02 +1.23%
MDTMedtronic plc99.94-0.67-0.67%24.78PE
After Hours 99.52 -0.42 -0.42%
QSIQuantum-Si0.909-0.161-15.05%-- 
After Hours 0.96 +0.051 +5.61%
ABTAbbott Laboratories103-0.87-0.84%38.76PE
After Hours 103.53 +0.53 +0.51%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety ofacute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.